These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 17177135)
1. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135 [TBL] [Abstract][Full Text] [Related]
2. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus]. Zhang XJ; Wang Z; Li HH; Yu L; Gao S Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671 [TBL] [Abstract][Full Text] [Related]
3. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus. Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110 [TBL] [Abstract][Full Text] [Related]
4. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691 [TBL] [Abstract][Full Text] [Related]
5. Serum apelin and resistin levels in patients with impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, and metabolic syndrome. Onalan E; Yakar B; Barım AO; Gursu MF Endokrynol Pol; 2020; 71(4):319-324. PubMed ID: 32716043 [TBL] [Abstract][Full Text] [Related]
6. Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration. Alexiadou K; Kokkinos A; Liatis S; Perrea D; Katsilambros N; Tentolouris N Hormones (Athens); 2012; 11(4):444-50. PubMed ID: 23422767 [TBL] [Abstract][Full Text] [Related]
7. Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus. Karatas A; Tunçay Işikkent N; Ozlü T; Demirin H Gynecol Endocrinol; 2014 May; 30(5):355-8. PubMed ID: 24512558 [TBL] [Abstract][Full Text] [Related]
8. Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations. Skoczylas A; Piecha G; Więcek A Pol Arch Med Wewn; 2016 Apr; 126(4):243-53. PubMed ID: 27129086 [TBL] [Abstract][Full Text] [Related]
9. Relationship between serum apelin, visfatin levels, and body composition in Polycystic Ovary Syndrome patients. Kuai D; Tang Q; Wang X; Yan Q; Tian W; Zhang H Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():24-29. PubMed ID: 38555852 [TBL] [Abstract][Full Text] [Related]
10. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. Zhang H; Xie H; Zhao Q; Xie GQ; Wu XP; Liao EY; Luo XH J Endocrinol Invest; 2010 Nov; 33(10):707-11. PubMed ID: 20208458 [TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes. Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474 [TBL] [Abstract][Full Text] [Related]
12. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance. Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512 [TBL] [Abstract][Full Text] [Related]
14. Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes. Zhu J; Schott M; Liu R; Liu C; Shen B; Wang Q; Mao X; Xu K; Wu X; Schinner S; Papewalis C; Scherbaum WA; Liu C Horm Metab Res; 2008 Nov; 40(11):801-5. PubMed ID: 18686225 [TBL] [Abstract][Full Text] [Related]
15. [Change and correlated factors of fasting level of the plasma endotoxin in subjects with different glucose tolerances and body mass indices]. Liu YH; Zhao TY; Hou LQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):769-73, 778. PubMed ID: 24325109 [TBL] [Abstract][Full Text] [Related]
16. Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure. Liakos CI; Sanidas EA; Perrea DN; Grassos CA; Chantziara V; Viniou NA; Barbetseas JD; Papadopoulos DP Am J Hypertens; 2016 May; 29(5):549-52. PubMed ID: 26276791 [TBL] [Abstract][Full Text] [Related]
17. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Chen MP; Chung FM; Chang DM; Tsai JC; Huang HF; Shin SJ; Lee YJ J Clin Endocrinol Metab; 2006 Jan; 91(1):295-9. PubMed ID: 16234302 [TBL] [Abstract][Full Text] [Related]
18. Adipokines: a novel link between adiposity and carotid plaque vulnerability. Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969 [TBL] [Abstract][Full Text] [Related]
19. Machine learning as new promising technique for selection of significant features in obese women with type 2 diabetes. Lotfi H; Pirmoradi S; Mahmoudi R; Teshnehlab M; Sheervalilou R; Fekri Aval S; Zarghami N Horm Mol Biol Clin Investig; 2020 Jan; 41(1):. PubMed ID: 31926078 [TBL] [Abstract][Full Text] [Related]
20. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Yang G; Li L; Chen W; Liu H; Boden G; Li K Ann Med; 2009; 41(1):52-6. PubMed ID: 18618352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]